{
  "debate_id": "2f078be0-05f8-4463-91bd-7f492f35b749",
  "judge_model": "x-ai/grok-4.1-fast",
  "judge_prompt": "p2",
  "run_number": 1,
  "judgment": "{\n  \"winner\": \"PRO\",\n  \"scores\": {\n    \"argument_quality\": {\n      \"PRO\": 5,\n      \"CON\": 5\n    },\n    \"evidence\": {\n      \"PRO\": 4,\n      \"CON\": 3\n    },\n    \"clash\": {\n      \"PRO\": 5,\n      \"CON\": 4\n    },\n    \"weighing\": {\n      \"PRO\": 4,\n      \"CON\": 3\n    }\n  },\n  \"confidence\": 0.7,\n  \"short_reason\": \"PRO wins with superior evidence (Nature Biotech, NAS study, 2018 incident) and direct clash refuting CON's innovation and community oversight claims, while better weighing catastrophic safety risks over benefits.\"\n}",
  "winner": "PRO",
  "scores": {
    "argument_quality": {
      "PRO": 5,
      "CON": 5
    },
    "evidence": {
      "PRO": 4,
      "CON": 3
    },
    "clash": {
      "PRO": 5,
      "CON": 4
    },
    "weighing": {
      "PRO": 4,
      "CON": 3
    }
  },
  "confidence": 0.7,
  "short_reason": "PRO wins with superior evidence (Nature Biotech, NAS study, 2018 incident) and direct clash refuting CON's innovation and community oversight claims, while better weighing catastrophic safety risks over benefits.",
  "timestamp": 1767861526.8464088,
  "saved_at": "2026-01-08T00:38:46.846758"
}